Melinda L. Tursky

Heart and Liver Defects and Reduced Transforming Growth Factor β2 Sensitivity in Transforming Growth Factor β Type III Receptor-Deficient Embryos

Kaye L. Stenvers, Melinda L. Tursky, Kenneth W. Harder et al. · Molecular and Cellular Biology · 2003 · 248 citations · Full text

Life Sciences, Developmental Biology, Genetics +17

Integrative Genomics Identifies the Molecular Basis of Resistance to Azacitidine Therapy in Myelodysplastic Syndromes

Ashwin Unnikrishnan, Elli Papaemmanuil, Dominik Beck et al. · Cell Reports · 2017 · 130 citations · Full text

Medicine, Hematology, Oncology +16

Delivery of PEGylated liposomal doxorubicin by bispecific antibodies improves treatment in models of high-risk childhood leukemia

Ernest Moles, Christopher B. Howard, Pie Huda et al. · Science Translational Medicine · 2023 · 41 citations · Full text

Pharmacy, Oncology, Pharmacology +17

<i>Ex vivo</i>expansion of haematopoietic stem/progenitor cells from human umbilical cord blood on acellular scaffolds prepared from MS-5 stromal cell line

Abhilasha Tiwari, Melinda L. Tursky, Dolly Mushahary et al. · Journal of Tissue Engineering and Regenerative Medicine · 2012 · 39 citations

Life Sciences, Bioengineering, Cell Biology +17

miR-10a as a therapeutic target and predictive biomarker for MDM2 inhibition in acute myeloid leukemia

Thi Thanh Vu, Friedrich Stölzel, Kristy W. Wang et al. · Leukemia · 2020 · 38 citations · Full text

Medicine, Oncology, Pharmacology +16